The weekend of Feb. 21-23, Mitchell and the UF brain tumor team he co-leads brought together expert investigators, physician-scientists and passionate supporters from across the U.S. and beyond to form new partnerships and collaborate in pursuit of discovering new immunotherapy regimens to improve quality of life and turn deadly brain cancers into livable diseases within 10 years.
Elias Sayour, M.D., Ph.D., a member of the UF Health Cancer Center and the Evelyn F. and William L. McKnight Brain Institute, received a $2.5 million grant from CureSearch for Children’s Cancer to undertake a first-in-human clinical trial to test a novel form of immunotherapy to treat the most aggressive forms of malignant brain tumors.
Watch an interview with Dr. Duane Mitchell, the co-director of the ReMission Alliance Against Brain Tumors, explaining how elite brain tumor researchers came together to form the Alliance, the benefits of team science, current treatment options and how research is advancing to provide more hope to those who are diagnosed with cancer, including children.
UF Health pediatric oncologist Elias Sayour, M.D., Ph.D., has received a $2.5 million grant from the pediatric cancer foundation CureSearch for Children’s Cancer to undertake a first-in-human clinical trial to test a novel form of immunotherapy to treat the most aggressive forms of malignant brain tumors.
